ALNY Alnylam Pharmaceuticals, Inc.

Fundamentals / CIK 0001178670 / USD

Alnylam Pharmaceuticals, Inc. reported $3.71B in revenue and net income of $2.65B for the fiscal year ended December 31, 2025 (up 65.2% year over year), with a 81.8% gross margin and a 13.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ALNY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$3.78B$1.89B$0-$1.37BFY 2016 Revenue: $47.16MFY 2016 Net Income: -$410.1M2016FY 2017 Revenue: $89.91MFY 2017 Net Income: -$490.9M2017FY 2018 Revenue: $74.91MFY 2018 Net Income: -$761.5M2018FY 2019 Revenue: $219.8MFY 2019 Net Income: -$886.1M2019FY 2020 Revenue: $492.9MFY 2020 Net Income: -$858.3M2020FY 2021 Revenue: $844.3MFY 2021 Net Income: -$852.8M2021FY 2022 Revenue: $1.04BFY 2022 Net Income: -$1.13B2022FY 2023 Revenue: $1.83BFY 2023 Net Income: -$440.2M2023FY 2024 Revenue: $2.25BFY 2024 Net Income: -$278.2M2024FY 2025 Revenue: $3.71BFY 2025 Net Income: $313.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $3.71B $2.25B $1.83B $1.04B $844.3M $492.9M $219.8M $74.91M $89.91M $47.16M
Cost of Revenue $677.2M $306.5M $268.2M $140.2M $115.0M $74.19M $25.06M $1.80M $0 --
Gross Profit $3.04B $1.94B $1.56B $897.2M $729.3M $418.7M $194.7M $73.11M $89.91M --
Research & Development $1.32B $1.13B $1.00B $883.0M $792.2M $654.8M $655.1M $505.4M $390.6M $382.4M
Selling, General & Admin $1.21B $975.5M $795.6M $770.7M $620.6M $588.4M $479.0M $382.4M $199.4M $89.35M
Total Operating Expenses -- -- -- -- -- -- -- -- $590.0M $471.7M
Operating Income $501.6M -$176.9M -$282.2M -$785.1M -$708.7M -$828.4M -$939.4M -$814.7M -$500.1M -$424.6M
EBITDA $557.2M -$120.2M -$228.1M -$740.6M -$661.1M -$793.7M -$922.3M -$799.4M -$486.7M -$409.5M
Interest Income $111.5M $122.0M $95.56M $24.81M $1.58M $11.81M $33.45M $29.26M -- --
Interest Expense $252.6M $141.9M $121.2M $156.0M $143.0M $84.50M $0 $0 -- --
Income Before Tax $323.2M -$377.4M -$433.5M -$1.13B -$852.1M -$855.6M -$885.3M -$760.7M -$490.9M -$410.1M
Income Tax Expense $9.40M -$99.22M $6.72M $4.16M $680K $2.68M $863K $823K $0 $0
Net Income $313.7M -$278.2M -$440.2M -$1.13B -$852.8M -$858.3M -$886.1M -$761.5M -$490.9M -$410.1M
Basic EPS $2.39 -$2.18 -$3.52 -$9.30 -$7.20 -$7.46 -$8.11 -$7.57 -$5.42 -$4.79
Diluted EPS $2.33 -$2.18 -$3.52 -$9.30 -$7.20 -$7.46 -$8.11 -$7.57 -$5.42 -$4.79
Basic Shares Outstanding 131.0M 127.7M 124.9M 121.7M 118.5M 115.0M 109.3M 100.6M 90.6M 85.6M
Diluted Shares Outstanding 134.7M 127.7M 124.9M 121.7M 118.5M 115.0M 109.3M 100.6M 90.6M 85.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.46B $1.29B -- $1.10B $1.25B $773.7M $594.2M $593.2M
Cost of Revenue $361.8M $298.3M -- $267.7M $197.2M $142.0M $70.18M $102.6M
Gross Profit $1.10B $992.7M -- $829.3M $1.05B $631.7M $524.0M $490.5M
Research & Development $408.5M $413.1M -- $372.2M $358.8M $323.6M $265.1M $300.2M
Selling, General & Admin $342.0M $347.9M -- $325.4M $322.1M $323.3M $239.9M $295.3M
Operating Income $345.8M $231.4M -- $131.7M $368.0M -$16.20M $18.08M -$105.2M
EBITDA -- -- -- $145.2M $381.8M -$2.25M $32.48M -$90.99M
Interest Income $30.94M $28.14M -- $26.63M $28.68M $27.49M $28.67M $31.02M
Interest Expense $84.37M $82.05M -- $65.40M $67.46M $61.46M $58.31M $38.97M
Income Before Tax $295.8M $177.8M -- $86.26M $280.6M -$41.31M -$2.37M -$194.0M
Income Tax Expense -$1.87B $13.31M -- -$25.28M -$12.12M $30.92M $15.88M -$110.2M
Net Income $2.17B $164.5M $206.0M $111.5M $292.7M -$72.23M -$18.25M -$83.76M
Basic EPS $16.19 $1.23 -- -- $2.23 -$0.55 -$0.14 --
Diluted EPS $15.72 $1.21 -- -- $2.14 -$0.55 -$0.14 --
Basic Shares Outstanding 133.8M 133.6M -- -- 131.4M 130.6M 129.7M --
Diluted Shares Outstanding 138.0M 138.3M -- -- 137.3M 130.6M 129.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.66B $966.4M $812.7M $866.4M $820.0M $496.6M $547.2M $420.1M $645.4M $193.6M
Short-Term Investments $1.25B $1.72B $1.62B $1.30B $1.55B $1.33B $975.0M $662.8M $1.05B $424.2M
Cash & Short-Term Investments $2.91B $2.69B $2.43B $2.16B $2.37B $1.83B $1.52B $1.08B $1.69B $617.8M
Accounts Receivable, Net $777.6M $405.3M $327.8M $238.0M $198.6M $102.4M $43.01M $18.76M $34.00M $23.33M
Inventory $82.72M $78.51M $89.15M $129.0M $86.36M $75.20M $56.35M $24.07M -- --
Total Current Assets $4.05B $3.30B $2.98B $2.69B $2.81B $2.61B $1.72B $1.20B $1.76B $671.9M
Property, Plant & Equipment, Net $513.1M $502.8M $526.1M $523.5M $502.0M $465.0M $425.2M $320.7M $181.9M $114.6M
Long-Term Investments -- -- -- -- -- -- -- -- $13.92M $324.8M
Other Non-Current Assets $59.46M $65.31M $61.90M $66.09M $60.20M $45.05M $18.07M $8.62M $4.17M $1.56M
Total Non-Current Assets $915.7M $944.7M $847.2M $854.1M $834.7M $792.3M $679.3M $374.1M $230.0M $590.9M
Total Assets $4.97B $4.24B $3.83B $3.55B $3.64B $3.41B $2.40B $1.57B $1.99B $1.26B
Accounts Payable $115.7M $88.42M $55.52M $98.09M $73.43M $51.97M $49.88M $59.71M $28.36M $54.47M
Deferred Revenue (Current) $4.84M $55.48M $102.8M $42.10M $149.5M $127.2M $77.82M $3.50M $41.70M $33.54M
Total Current Liabilities $1.47B $1.19B $967.8M $767.9M $695.7M $585.3M $352.6M $179.5M $144.3M $131.7M
Long-Term Debt -- -- -- -- $675.7M $191.3M -- -- -- --
Deferred Revenue (Non-Current) -- $0 $188.2M $193.8M $152.4M $225.1M $318.4M $458K $43.08M $49.39M
Other Non-Current Liabilities $7.59M $4.97M $308.4M $212.6M $98.96M $37.91M $9.33M $4.96M $4.35M $3.07M
Total Non-Current Liabilities $2.71B $2.99B $3.08B $2.94B $2.36B $1.81B $603.8M $93.34M $84.05M $210.9M
Total Liabilities $4.18B $4.17B $4.05B $3.70B $3.06B $2.39B $956.4M $272.8M $228.3M $342.6M
Total Debt (incl. Leases) $270.6M $271.4M $284.6M $303.3M $997.6M $521.2M $303.8M -- -- --
Common Stock $1.32M $1.29M $1.26M $1.24M $1.20M $1.16M $1.12M $1.01M $997K $859K
Retained Earnings -$6.70B -$7.29B -$7.01B -$6.57B -$5.44B -$4.59B -$3.73B -$2.84B -$2.15B -$1.66B
Accumulated Other Comp. Income -$20.10M -$34.52M -$23.38M -$44.65M -$33.26M -$43.62M -$36.52M -$33.21M -$34.43M -$33.44M
Total Stockholders' Equity $789.2M $67.09M -$220.6M -$158.2M $588.2M $1.02B $1.44B $1.30B $1.77B $920.2M
Total Equity $789.2M $67.09M -$220.6M -$158.2M $588.2M $1.02B $1.44B $1.30B $1.77B $920.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $1.75B $1.71B $1.66B $1.49B $1.11B $1.02B $966.4M $1.10B
Short-Term Investments $1.83B $1.60B $1.25B $1.23B $1.74B $1.61B $1.72B $1.67B
Cash & Short-Term Investments $3.59B $3.31B $2.91B $2.72B $2.86B $2.63B $2.69B $2.77B
Accounts Receivable, Net $1.08B $912.7M $777.6M $964.8M $567.1M $418.0M $405.3M $353.9M
Inventory $105.9M $97.11M $82.72M $75.38M $71.69M $65.58M $78.51M $75.99M
Total Current Assets $5.11B $4.62B $4.05B $3.95B $3.64B $3.27B $3.30B $3.36B
Property, Plant & Equipment, Net $614.9M $554.1M $513.1M $501.8M $499.8M $498.7M $502.8M $507.0M
Other Non-Current Assets $60.31M $65.13M $59.46M $55.84M $57.17M $73.82M $65.31M $77.62M
Total Non-Current Assets $2.88B $938.6M $915.7M $898.9M $922.3M $945.6M $944.7M $849.6M
Total Assets $7.99B $5.56B $4.97B $4.85B $4.57B $4.21B $4.24B $4.21B
Accounts Payable $135.4M $108.0M $115.7M $117.6M $102.4M $97.40M $88.42M $70.81M
Deferred Revenue (Current) $11.67M $4.01M $4.84M $2.54M $15.08M $28.16M $55.48M $71.03M
Total Current Liabilities $2.06B $1.51B $1.47B $1.56B $1.30B $1.08B $1.19B $1.22B
Deferred Revenue (Non-Current) -- -- -- -- -- -- $0 $1.01M
Other Non-Current Liabilities $10.61M $9.15M $7.59M $9.77M $10.93M $5.87M $4.97M $357.5M
Total Non-Current Liabilities $2.33B $2.69B $2.71B $3.06B $3.01B $3.02B $2.99B $2.95B
Total Liabilities $4.39B $4.20B $4.18B $4.62B $4.32B $4.10B $4.17B $4.17B
Total Debt (incl. Leases) $249.4M $256.4M $270.6M $268.2M $270.5M $276.1M $271.4M $278.2M
Common Stock $1.34M $1.34M $1.32M $1.32M $1.31M $1.30M $1.29M $1.29M
Retained Earnings -$4.16B -$6.33B -$6.70B -$7.16B -$7.41B -$7.35B -$7.29B -$7.20B
Accumulated Other Comp. Income -$44.66M -$32.14M -$20.10M -$21.77M -$29.95M -$37.52M -$34.52M -$24.83M
Total Stockholders' Equity $3.60B $1.35B $789.2M $580.2M $555.3M $426.1M $67.09M $32.35M
Total Equity $3.60B $1.35B $789.2M $580.2M $555.3M $426.1M $67.09M $32.35M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $313.7M -$278.2M -$440.2M -$1.13B -$852.8M -$858.3M -$886.1M -$761.5M -$490.9M -$410.1M
Depreciation & Amortization $55.66M $56.67M $54.05M $44.47M $47.57M $34.77M $17.18M $15.25M $13.37M $15.13M
Stock-Based Compensation $348.2M $272.1M $221.7M $230.6M $165.7M $139.9M $174.8M $157.8M $92.82M $75.53M
Change in Receivables -$360.0M -$86.55M -$87.94M -$45.60M -$101.8M -$56.24M -$24.24M $15.24M -$10.67M -$15.04M
Change in Inventory $8.47M $13.59M $18.37M -$34.14M -$26.41M -$35.43M -$32.41M -$22.64M $0 --
Change in Payables -- -- -- -- -- -- -- $15.48M -$4.94M $10.10M
Operating Cash Flow $524.1M -$8.31M $104.2M -$541.3M -$641.7M -$615.0M -$278.4M -$562.6M -$382.8M -$307.7M
Capital Expenditure -$58.70M -$34.28M -$62.21M -$72.06M -$76.37M -$70.36M -$140.2M -$126.9M -$104.2M -$64.56M
Free Cash Flow $465.4M -$42.59M $41.95M -$613.3M -$718.1M -$685.3M -$418.6M -$689.5M -$487.0M -$372.3M
Purchases of Investments -$1.31B -$1.63B -$1.82B -$1.98B -$1.66B -$2.03B -$2.08B -$1.10B -$903.5M -$759.3M
Investing Cash Flow $436.3M -$116.8M -$336.4M $169.4M -$273.3M -$435.5M -$417.7M $272.9M -$290.4M $142.6M
Common Stock Issued -- -- -- -- $0 $0 $381.9M $0 $1.14B --
Financing Cash Flow -$305.2M $294.2M $172.1M $425.8M $1.25B $995.0M $823.2M $65.47M $1.12B $177.8M
Net Change in Cash $690.2M $153.8M -$53.67M $46.40M $323.1M -$50.58M $127.0M -$224.2M $451.7M $12.72M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $2.17B $164.5M $206.0M $111.5M $292.7M -$72.23M -$18.25M -$83.76M
Depreciation & Amortization -- -- -- $13.51M $13.80M $13.94M $14.40M $14.17M
Stock-Based Compensation $79.12M $86.62M -- $71.63M $108.2M $111.7M $56.71M $91.64M
Change in Receivables -- -- -- $184.2M -$399.9M -$136.9M -$7.43M -$59.51M
Change in Inventory -- -- -- -$13.86M $4.98M $11.14M $6.21M $849K
Operating Cash Flow -- -- -- $217.7M $296.9M $127.8M -$118.3M -$94.66M
Capital Expenditure -- -- -- -$23.29M -$12.14M -$14.29M -$8.97M -$9.09M
Free Cash Flow -- -- -- $194.4M $284.7M $113.5M -$127.3M -$103.8M
Purchases of Investments -- -- -- -$235.9M -$208.0M -$459.6M -$401.6M -$486.7M
Investing Cash Flow -- -- -- -$37.17M $501.1M -$141.4M $113.8M -$52.91M
Financing Cash Flow -- -- -- -$8.86M -$420.1M $79.68M $44.08M $31.00M
Net Change in Cash -- -- -- $166.0M $376.9M $93.61M $53.60M -$133.8M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 81.8% 86.4% 85.3% 86.5% 86.4% 84.9% 88.6% 97.6% 100.0% --
Operating Margin 13.5% -7.9% -15.4% -75.7% -83.9% -168.1% -427.5% -1087.6% -556.2% -900.3%
Net Profit Margin 8.4% -12.4% -24.1% -109.0% -101.0% -174.1% -403.2% -1016.6% -545.9% -869.6%
Return on Equity (ROE) 39.8% -414.6% -- -- -145.0% -84.5% -61.6% -58.5% -27.8% -44.6%
Return on Assets (ROA) 6.3% -6.6% -11.5% -31.9% -23.4% -25.2% -37.0% -48.4% -24.6% -32.5%
Current Ratio 2.76x 2.78x 3.08x 3.51x 4.04x 4.47x 4.87x 6.69x 12.23x 5.10x
Quick Ratio 2.71x 2.71x 2.99x 3.34x 3.91x 4.34x 4.71x 6.56x 11.96x 4.87x
Debt to Equity 0.34x 4.05x -- -- 1.70x 0.51x 0.21x -- -- --
Revenue Growth (YoY) +65.2% +23.0% +76.2% +22.9% +71.3% +124.3% +193.4% -16.7% +90.7% --
Gross Profit Growth (YoY) +56.4% +24.5% +73.9% +23.0% +74.2% +115.0% +166.3% -18.7% -- --
Operating Cash Flow Growth (YoY) -- -108.0% -- -- -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -201.5% -- -- -- -- -- -- -- --
5Y Revenue / Share Growth +561.4% +775.7% +1865.6% +758.6% +1193.7% -- -- -- -- --
10Y Revenue / Share Growth -- -- -- -- -- +80.1% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- 81.8% 84.0% 83.9% 86.3% 86.4%
Operating Margin -- -- -- 13.5% 8.2% -7.3% -4.9% -7.9%
Net Profit Margin -- -- -- 8.4% 3.7% -11.6% -9.8% -12.4%
Return on Equity (ROE) 73.5% 57.2% -- 39.8% 20.4% -51.5% -54.1% -414.6%
Return on Assets (ROA) 33.1% 13.9% -- 6.3% 2.4% -6.3% -5.5% -6.6%
Current Ratio 2.48x 3.05x -- 2.76x 2.54x 2.80x 3.04x 2.78x
Quick Ratio 2.43x 2.99x -- 2.71x 2.49x 2.75x 2.98x 2.71x
Debt to Equity 0.07x 0.19x -- 0.34x 0.46x 0.49x 0.65x 4.05x
Revenue Growth (YoY) +16.7% +66.9% -- +84.9% +149.3% +17.3% +20.2% +34.9%
Gross Profit Growth (YoY) +4.2% +57.2% -- +69.1% +151.1% +6.6% +19.2% +33.4%
Operating Income Growth (YoY) -6.0% -- -- -- -- -133.3% -- --
Net Income Growth (YoY) +640.5% -- -- -- -- -- -- --
EPS Growth (YoY) +626.0% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- +579.2% +2.9% -- --
Free Cash Flow Growth (YoY) -- -- -- -- +620.5% -2.3% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001178670) · from December 31, 2008 Data through September 30, 2026 · synced Nov 20, 2026, 05:06 UTC · Open in terminal